VivoSim Labs, Inc. Capital Leases, Income Statement, Amortization Expense
VivoSim Labs, Inc. (VIVS) reported Capital Leases, Income Statement, Amortization Expense of $6.80 thousand for the 12-month period ending 2014-03-31, per its 10-K filed 2014-06-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:CapitalLeasesIncomeStatementAmortizationExpense · last filed 2014-06-10
- VivoSim Labs, Inc. capital leases, income statement, amortization expense for the quarter ending 2013-03-31 was $1.70K.
- VivoSim Labs, Inc. capital leases, income statement, amortization expense for fiscal 2014 was $6.80K.
- VivoSim Labs, Inc. capital leases, income statement, amortization expense for fiscal 2012 was $2.90K.
| Period end | Capital Leases, Income Statement, Amortization Expense 3 month | Capital Leases, Income Statement, Amortization Expense 12 month |
|---|---|---|
| 2014-03-31 | $6.80K 10-K · filed 2014-06-10 | |
| 2013-03-31 | $1.70K 10-K · filed 2014-06-10 | |
| 2012-12-31 | $2.90K 10-K · filed 2014-06-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |